
Valley Ventures
Description
Valley Ventures is a seasoned venture capital firm based in Phoenix, Arizona, with a rich history dating back to its establishment in 1985. Operating as a family of institutionally-funded partnerships, the firm has consistently supported high-growth potential companies across various sectors for nearly four decades. Their long-standing presence in the venture ecosystem underscores a commitment to fostering innovation and scaling promising startups, primarily within the United States.
The firm's investment strategy focuses on early-stage companies, spanning Seed, Series A, and Series B rounds. Valley Ventures seeks out businesses demonstrating strong growth trajectories and disruptive potential. Their initial investments typically range from $1 million to $5 million, with a strategic allocation of reserves for subsequent follow-on rounds to support portfolio companies through their growth phases. This approach allows them to be a consistent partner from early development through significant scaling milestones.
Over its operational history, Valley Ventures has successfully raised and deployed significant capital across six distinct funds. Their most recent fund, Valley Ventures VI, closed in 2019 with $200 million, contributing to a cumulative total of $625 million raised across their last four funds (Valley Ventures III, IV, V, and VI). This substantial capital base has enabled them to invest in over 100 companies, resulting in numerous successful exits and a diversified portfolio that reflects their broad sector interest and commitment to long-term value creation.
Investor Profile
Valley Ventures has backed more than 26 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 15% of its total and boasts 5 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series A, Series B, Series C rounds (top funding stages).
- Majority of deals are located in United States, United Kingdom, Israel.
- Strong thematic focus on Biotechnology, Health Care, Medical.
- Typical check size: $1M – $5M.
Stage Focus
- Series A (35%)
- Series B (23%)
- Series C (15%)
- Series Unknown (8%)
- Series D (8%)
- Seed (8%)
- Series E (4%)
Country Focus
- United States (92%)
- United Kingdom (4%)
- Israel (4%)
Industry Focus
- Biotechnology
- Health Care
- Medical
- Genetics
- Health Diagnostics
- Life Science
- Electronics
- Manufacturing
- Semiconductor
- Therapeutics
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.